-
1
-
-
10944239058
-
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1999 guideline for the management of patients with acute myocardial infarction)
-
Antman EM, Anbe DT, Armstrong PW, et al.: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1999 guideline for the management of patients with acute myocardial infarction). Circulation 2004, 110:e82-e292.
-
(2004)
Circulation
, vol.110
-
-
Antman, E.M.1
Anbe, D.T.2
Armstrong, P.W.3
-
2
-
-
38049172418
-
focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association task force on practice guidelines
-
June, in press
-
Antman EM, Hand M, Armstrong PW, et al.: June 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2007, in press.
-
(2007)
Circulation
-
-
Antman, E.M.1
Hand, M.2
Armstrong, P.W.3
-
3
-
-
0037232464
-
Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of acute myocardial infarction of the European Society of Cardiology
-
Van de Werf F, Ardissino D, Betriu A, et al.: Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of acute myocardial infarction of the European Society of Cardiology. Eur Heart J 2003, 24:28-66.
-
(2003)
Eur Heart J
, vol.24
, pp. 28-66
-
-
Van de Werf, F.1
Ardissino, D.2
Betriu, A.3
-
4
-
-
0036788546
-
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Summary article
-
A report of the American College of Cardiology/American Heart Association task force on practice guidelines Committee on the management of patients with unstable angina
-
Braunwald E, Antman EM, Beasley JW, et al.: ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: summary article. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the management of patients with unstable angina). Circulation 2002, 106:1893-1900.
-
(2002)
Circulation
, vol.106
, pp. 1893-1900
-
-
Braunwald, E.1
Antman, E.M.2
Beasley, J.W.3
-
5
-
-
0036892858
-
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
-
Bertrand ME, Simoons ML, Fox KA, et al.: Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002, 23:1809-1840.
-
(2002)
Eur Heart J
, vol.23
, pp. 1809-1840
-
-
Bertrand, M.E.1
Simoons, M.L.2
Fox, K.A.3
-
6
-
-
34447555473
-
-
Konkle BA, Schafer AI: Hemostasis, thrombosis, fibrinolysis, and cardiovascular disease. In Braunwald's Heart Disease, 2, edn 7. Edited by Braunwald E, Zipes DP, Libby P, Bonow RO. Philadelphia: WB Saunders; 2005:2067-2092.
-
Konkle BA, Schafer AI: Hemostasis, thrombosis, fibrinolysis, and cardiovascular disease. In Braunwald's Heart Disease, vol 2, edn 7. Edited by Braunwald E, Zipes DP, Libby P, Bonow RO. Philadelphia: WB Saunders; 2005:2067-2092.
-
-
-
-
7
-
-
2542581490
-
Bivalirudin: An anticoagulant option for percutaneous coronary intervention
-
Bates ER: Bivalirudin: an anticoagulant option for percutaneous coronary intervention. Expert Rev Cardiovasc Ther 2004:153-162.
-
(2004)
Expert Rev Cardiovasc Ther
, pp. 153-162
-
-
Bates, E.R.1
-
8
-
-
0036660207
-
Thrombin functions during tissue factor-induced blood coagulation
-
Brummel KE, Paradis SG, Butenas S, Mann KG: Thrombin functions during tissue factor-induced blood coagulation. Blood 2002, 100:148-152.
-
(2002)
Blood
, vol.100
, pp. 148-152
-
-
Brummel, K.E.1
Paradis, S.G.2
Butenas, S.3
Mann, K.G.4
-
9
-
-
0034971291
-
A cell-based model of hemostasis
-
Hoffman M, Monroe DM: A cell-based model of hemostasis. Thromb Haemost 2001, 85, 958-965.
-
(2001)
Thromb Haemost
, vol.85
, pp. 958-965
-
-
Hoffman, M.1
Monroe, D.M.2
-
11
-
-
0034648757
-
-
Coughlin SR: Thrombin signaling and protease-activated receptors. Nature 2000, 407:2S8-264.
-
Coughlin SR: Thrombin signaling and protease-activated receptors. Nature 2000, 407:2S8-264.
-
-
-
-
12
-
-
0027240597
-
An international randomized trial comparing four thrombolytic strategies for acute myocardial infafction
-
The GUSTO Investigators
-
The GUSTO Investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infafction. N Engl J Med 1993, 329:673-682.
-
(1993)
N Engl J Med
, vol.329
, pp. 673-682
-
-
-
13
-
-
0030893793
-
Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction
-
Collins R, Peto R, Baigent C, Sleight P: Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med 1997, 336:847-860.
-
(1997)
N Engl J Med
, vol.336
, pp. 847-860
-
-
Collins, R.1
Peto, R.2
Baigent, C.3
Sleight, P.4
-
14
-
-
0037438875
-
Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention
-
Wong GC, Giugliano RP, Antman EM: Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention. JAMA 2003, 289:331-342.
-
(2003)
JAMA
, vol.289
, pp. 331-342
-
-
Wong, G.C.1
Giugliano, R.P.2
Antman, E.M.3
-
15
-
-
0035949117
-
Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomised trial in acute myocardial infarction
-
ASSENT-3 Investigators
-
ASSENT-3 Investigators: Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 2001, 358:605-613.
-
(2001)
Lancet
, vol.358
, pp. 605-613
-
-
-
16
-
-
0038447936
-
Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 plus randomized trial in acute myocardial infarction
-
Wallentin L, Goldstein P, Armstrong PW, ct al.: Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 plus randomized trial in acute myocardial infarction. Circulation 2003, 108:135-142.
-
(2003)
Circulation
, vol.108
, pp. 135-142
-
-
Wallentin, L.1
Goldstein, P.2
Armstrong, P.W.3
ct al4
-
17
-
-
33645515458
-
Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction
-
Antman EM, Morrow DA, McCabe CH, et al.: Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 2006, 354:1477-1488.
-
(2006)
N Engl J Med
, vol.354
, pp. 1477-1488
-
-
Antman, E.M.1
Morrow, D.A.2
McCabe, C.H.3
-
18
-
-
34249824588
-
Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin following fibrinolytic therapy for ST-elevation myocardial infarction in the EXTRACT-TIMI 25 trial
-
in press
-
Gibson CM, Murphy SA, Montalescot G, et al.: Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin following fibrinolytic therapy for ST-elevation myocardial infarction in the EXTRACT-TIMI 25 trial. J Am Coll Cardiol 2007, in press.
-
(2007)
J Am Coll Cardiol
-
-
Gibson, C.M.1
Murphy, S.A.2
Montalescot, G.3
-
19
-
-
33645497961
-
Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction. The OASIS-6 randomized trial
-
Yusuf S, Mehta SR, Chrolavicius S, et al.: Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction. The OASIS-6 randomized trial. JAMA 2006, 295:1519-1530.
-
(2006)
JAMA
, vol.295
, pp. 1519-1530
-
-
Yusuf, S.1
Mehta, S.R.2
Chrolavicius, S.3
-
20
-
-
0030771823
-
Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) trial investigators
-
White HD, Aylward PE, Frey MJ, et al.: Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) trial investigators. Circulation 1997, 96:2155-2161.
-
(1997)
Circulation
, vol.96
, pp. 2155-2161
-
-
White, H.D.1
Aylward, P.E.2
Frey, M.J.3
-
21
-
-
0035651983
-
Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: The HERO-2 randomised trial
-
White H: Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. Lancet 2001, 358:1855-1863.
-
(2001)
Lancet
, vol.358
, pp. 1855-1863
-
-
White, H.1
-
22
-
-
0034600424
-
Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: A meta-analysis
-
Eikelboom JW, Anand SS, Malmberg K, et al.: Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis. Lancet 2000, 355:1936-1942.
-
(2000)
Lancet
, vol.355
, pp. 1936-1942
-
-
Eikelboom, J.W.1
Anand, S.S.2
Malmberg, K.3
-
23
-
-
8544279582
-
A comparison of low-molecular weight heparin with unfractionated heparin for unstable coronary artery disease
-
Cohen M, Demers C, Gurfinkel EP, et al.: A comparison of low-molecular weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997, 337:447-452.
-
(1997)
N Engl J Med
, vol.337
, pp. 447-452
-
-
Cohen, M.1
Demers, C.2
Gurfinkel, E.P.3
-
24
-
-
0032870952
-
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: Results of the TIMI 11B trial
-
Antman EA, McCabe CH, Gurfinkel EP, et al.: Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: results of the TIMI 11B trial. Circulation 1999, 100:1593-1601.
-
(1999)
Circulation
, vol.100
, pp. 1593-1601
-
-
Antman, E.A.1
McCabe, C.H.2
Gurfinkel, E.P.3
-
25
-
-
0032855125
-
Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis
-
Antman EM, Cohen M, Radley D, et al.: Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis. Circulation 1999, 100:1602-1608.
-
(1999)
Circulation
, vol.100
, pp. 1602-1608
-
-
Antman, E.M.1
Cohen, M.2
Radley, D.3
-
26
-
-
0036735080
-
Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study
-
Cohen M, Theroux P, Borzak S, et al.: Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. Am Heart j 2002, 144:470-477.
-
(2002)
Am Heart j
, vol.144
, pp. 470-477
-
-
Cohen, M.1
Theroux, P.2
Borzak, S.3
-
27
-
-
0037458122
-
Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide
-
Goodman SG, Fitchett D, Armstrong PW, et al.: Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Circulation 2003, 107:238-244.
-
(2003)
Circulation
, vol.107
, pp. 238-244
-
-
Goodman, S.G.1
Fitchett, D.2
Armstrong, P.W.3
-
28
-
-
3042820414
-
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: A randomized controlled trial
-
Blazing MA, de Lemos JA, White HD, et al.: Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial. JAMA 2004, 292:55-64.
-
(2004)
JAMA
, vol.292
, pp. 55-64
-
-
Blazing, M.A.1
de Lemos, J.A.2
White, H.D.3
-
29
-
-
3042782723
-
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial
-
The SYNERGY Trial Investigators
-
The SYNERGY Trial Investigators: Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 2004, 292:45-54.
-
(2004)
JAMA
, vol.292
, pp. 45-54
-
-
-
30
-
-
3042784252
-
Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes. A systemic overview
-
Petersen JL, Mahaffey KW, Hasselblad V, et al.: Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes. A systemic overview. JAMA 2004, 292:89-96.
-
(2004)
JAMA
, vol.292
, pp. 89-96
-
-
Petersen, J.L.1
Mahaffey, K.W.2
Hasselblad, V.3
-
31
-
-
33645498094
-
Comparison of fondaparinux and enoxaparin in acute coronary syndromes
-
for the OASIS-5 Investigators
-
Yusuf S, Mehta SR, Chrolavicius S, et al.: for the OASIS-5 Investigators: Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006, 354:1464-1476.
-
(2006)
N Engl J Med
, vol.354
, pp. 1464-1476
-
-
Yusuf, S.1
Mehta, S.R.2
Chrolavicius, S.3
-
32
-
-
0036482419
-
Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: Observations from the TIMI 8 trial
-
Antman EM, McCabe CH, Braunwald E: Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. Am Heart J 2002, 143:229-234.
-
(2002)
Am Heart J
, vol.143
, pp. 229-234
-
-
Antman, E.M.1
McCabe, C.H.2
Braunwald, E.3
-
33
-
-
0037453968
-
Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention. REPLACE-2 randomized trial
-
for the REPLACE-2 Investigators
-
Lincoff AM, Bittl JA, Harrington RA, et al.: for the REPLACE-2 Investigators: Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention. REPLACE-2 randomized trial. JAMA 2003:289:853-863.
-
(2003)
JAMA
, vol.289
, pp. 853-863
-
-
Lincoff, A.M.1
Bittl, J.A.2
Harrington, R.A.3
-
34
-
-
33745675382
-
Outcomes of patients with acute coronary syndromes who are treated with bivalidurin during percutaneous coronary intervention: An analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial
-
Rajagopal V, Lincoff AM, Cohen DJ, et al.: Outcomes of patients with acute coronary syndromes who are treated with bivalidurin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial. Am Heart J 2006, 152:149-154.
-
(2006)
Am Heart J
, vol.152
, pp. 149-154
-
-
Rajagopal, V.1
Lincoff, A.M.2
Cohen, D.J.3
-
35
-
-
33744975578
-
A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: The PROTECT-TIMI 30 trial
-
Gibson CM, Morrow DA, Murphy SA, et al.: A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI 30 trial. J Am Coll Cardiol 2006, 47.2364-2373.
-
(2006)
J Am Coll Cardiol
, vol.47
, pp. 2364-2373
-
-
Gibson, C.M.1
Morrow, D.A.2
Murphy, S.A.3
-
36
-
-
33751221316
-
Bivalirudin for patients with acute coronary syndromes
-
for the ACUITY Investigators
-
Stone GW, McLaurin BT, Cox DA, et al.: for the ACUITY Investigators: Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006, 355:2203-2216.
-
(2006)
N Engl J Med
, vol.355
, pp. 2203-2216
-
-
Stone, G.W.1
McLaurin, B.T.2
Cox, D.A.3
-
37
-
-
33947187284
-
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial
-
Stone GW, White HD, Ohman EM, et al.: Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Lancet 2007, 369:907-919.
-
(2007)
Lancet
, vol.369
, pp. 907-919
-
-
Stone, G.W.1
White, H.D.2
Ohman, E.M.3
-
38
-
-
0029938993
-
Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: Results from the GUSTO-1 trial
-
Granger CB, Hirsch J, Califf RM, et al.: Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-1 trial. Circulation 1996, 93:870-878.
-
(1996)
Circulation
, vol.93
, pp. 870-878
-
-
Granger, C.B.1
Hirsch, J.2
Califf, R.M.3
-
39
-
-
27144475755
-
Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes
-
Rao SV, O'Grady K, Pieper KS, et al.: Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol 2005, 96:1200-1206.
-
(2005)
Am J Cardiol
, vol.96
, pp. 1200-1206
-
-
Rao, S.V.1
O'Grady, K.2
Pieper, K.S.3
-
40
-
-
29544437848
-
Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-elevation acute coronary syndromes
-
Alexander KP, Chen AY, Roe MT, et al.: Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-elevation acute coronary syndromes. JAMA 2006, 295:3108-3116.
-
(2006)
JAMA
, vol.295
, pp. 3108-3116
-
-
Alexander, K.P.1
Chen, A.Y.2
Roe, M.T.3
-
41
-
-
4644350897
-
Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes
-
Rao SV, Jollis JG, Harrington RA, et al.: Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004, 292:1555-1562.
-
(2004)
JAMA
, vol.292
, pp. 1555-1562
-
-
Rao, S.V.1
Jollis, J.G.2
Harrington, R.A.3
|